Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ginsberg

Showing results (581-590 of 607) with videos related to

Pageof 61
Sort By:
Current Biology : CB|March 13, 2018
Rapid Global Spread of wRi-like Wolbachia across Multiple DrosophilaMichael Turelli, Brandon S Cooper, Kelly M Richardson, et al.
Blood|March 2, 2018
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolismClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
Blood|September 16, 2008
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trialClive Kearon, Jim A Julian, Michael J Kovacs, et al.
Annals of Internal Medicine|January 16, 2013
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trialLori-Ann Linkins, Shannon M Bates, Eddy Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2019
Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) BlockadeJuan C Osorio, Kathryn C Arbour, Dung T Le, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factorC Kearon, J S Ginsberg, D R Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2025
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung CancerAndreas Rimner, Benjamin H Lok, Daphna Y Gelblum, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2013
Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancersJamie E Chaft, Valerie Rusch, Michelle S Ginsberg, et al.
Science Translational Medicine|July 8, 2011
Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modelingJuliann Chmielecki, Jasmine Foo, Geoffrey R Oxnard, et al.
Annals of Surgery|November 29, 2012
Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective studyJosé G Guillem, Jeannine A Ruby, Tobias Leibold, et al.
Pageof 61

Showing results (581-590 of 607) with videos related to

Sort By:
Pageof 61
Current Biology : CB|March 13, 2018
Rapid Global Spread of wRi-like Wolbachia across Multiple DrosophilaMichael Turelli, Brandon S Cooper, Kelly M Richardson, et al.
Blood|March 2, 2018
Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolismClive Kearon, Sameer Parpia, Frederick A Spencer, et al.
Blood|September 16, 2008
Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trialClive Kearon, Jim A Julian, Michael J Kovacs, et al.
Annals of Internal Medicine|January 16, 2013
Selective D-dimer testing for diagnosis of a first suspected episode of deep venous thrombosis: a randomized trialLori-Ann Linkins, Shannon M Bates, Eddy Lang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2019
Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) BlockadeJuan C Osorio, Kathryn C Arbour, Dung T Le, et al.
Journal of Thrombosis and Haemostasis : JTH|April 22, 2004
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factorC Kearon, J S Ginsberg, D R Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2025
Phase I Dose Escalation Trial Combining Olaparib and Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung CancerAndreas Rimner, Benjamin H Lok, Daphna Y Gelblum, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 17, 2013
Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancersJamie E Chaft, Valerie Rusch, Michelle S Ginsberg, et al.
Science Translational Medicine|July 8, 2011
Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modelingJuliann Chmielecki, Jasmine Foo, Geoffrey R Oxnard, et al.
Annals of Surgery|November 29, 2012
Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective studyJosé G Guillem, Jeannine A Ruby, Tobias Leibold, et al.
Pageof 61